Vincerx Pharma, Inc. (VINC)

Market Cap	65.95K -98.2%
Revenue (ttm)	n/a
Net Income	-22.65M
EPS	-8.98
Shares Out	5.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	390
Average Volume	5,720
Open	0.0126
Previous Close	n/a
Day's Range	0.0126 - 0.0126
52-Week Range	0.0002 - 1.2200
Beta	1.55
RSI	47.36
Earnings Date	Mar 27, 2026

About Vincerx Pharma

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx bioconjugation platform combines different targeting, linker, and payload technologies to develop antibody-drug conjugates (ADC) and small molecule drug conjugates (SMDC); and provides CellTrapper technology for use in reduction of payload cellular permeability. The company develops VIP943, an antibody drug conjugate in Phase 1 d...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Employees: 13
• Stock Exchange: OTCMKTS
• Ticker Symbol: VINC